BioBone – A Prospective, Blinded, Multicenter Validation Study of the CD8 + Terminal Differentiated Effector Memory Cells (CD8 + TEMRA Cells) As Prognostic Biomarker for Disturbed Fracture Healing – Study Design
Journal of Orthopaedic Surgery and Research(2025)
Charité – Universitätsmedizin Berlin
Abstract
The BioBone consortium aims to validate circulating CD8 + TEMRA cells as a prognostic biomarker for predicting impaired fracture healing outcomes in a prospective, blinded, multicenter clinical study. The primary performance parameters are the pre-operative identification of at least 30
MoreTranslated text
Key words
Long bone fracture,Impaired healing,CD8 + TEMRA,Prognostic biomarker
PDF
View via Publisher
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper
Summary is being generated by the instructions you defined